The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan

Karen-Lise Garm Spindler; B.V. Vittrup; I.C. Christensen; J. S. Schou; A.J. Jakobsen; Estrid Vilma Solyom Høgdall; Niels Pallisgaard; D. N. Nielsen; Helle Hjorth Johannesen; J. H. Johansen

The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan

Karen-Lise Garm Spindler, B.V. Vittrup, I.C. Christensen, J. S. Schou, A.J. Jakobsen, Estrid Vilma Solyom Høgdall, Niels Pallisgaard, D. N. Nielsen, Helle Hjorth Johannesen, J. H. Johansen

Institut for Klinisk Medicin

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Annals of Oncology
Vol/bind	21
Sider (fra-til)	I39-I39
ISSN	0923-7534
Status	Udgivet - 2010

Citationsformater

Spindler, K-L. G., Vittrup, B. V., Christensen, I. C., Schou, J. S., Jakobsen, A. J., Høgdall, E. V. S., Pallisgaard, N., Nielsen, D. N., Johannesen, H. H., & Johansen, J. H. (2010). The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan. Annals of Oncology, 21, I39-I39.

The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan. / Spindler, Karen-Lise Garm; Vittrup, B.V.; Christensen, I.C.; Schou, J. S.; Jakobsen, A.J.; Høgdall, Estrid Vilma Solyom; Pallisgaard, Niels; Nielsen, D. N.; Johannesen, Helle Hjorth; Johansen, J. H.

I: Annals of Oncology, Bind 21, 2010, s. I39-I39.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Spindler, Karen-Lise Garm ; Vittrup, B.V. ; Christensen, I.C. ; Schou, J. S. ; Jakobsen, A.J. ; Høgdall, Estrid Vilma Solyom ; Pallisgaard, Niels ; Nielsen, D. N. ; Johannesen, Helle Hjorth ; Johansen, J. H. / The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan. I: Annals of Oncology. 2010 ; Bind 21. s. I39-I39.

@article{ff3242d25c5849989c3baf8c8161a234,

title = "The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan",

author = "Spindler, {Karen-Lise Garm} and B.V. Vittrup and I.C. Christensen and Schou, {J. S.} and A.J. Jakobsen and H{\o}gdall, {Estrid Vilma Solyom} and Niels Pallisgaard and Nielsen, {D. N.} and Johannesen, {Helle Hjorth} and Johansen, {J. H.}",

year = "2010",

language = "English",

volume = "21",

pages = "I39--I39",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - ABST

T1 - The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan

AU - Spindler, Karen-Lise Garm

AU - Vittrup, B.V.

AU - Christensen, I.C.

AU - Schou, J. S.

AU - Jakobsen, A.J.

AU - Høgdall, Estrid Vilma Solyom

AU - Pallisgaard, Niels

AU - Nielsen, D. N.

AU - Johannesen, Helle Hjorth

AU - Johansen, J. H.

PY - 2010

Y1 - 2010

M3 - Conference abstract in journal

VL - 21

SP - I39-I39

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -